AAAAAA
Results:
1-13
|
Results: 13
Authors:
RISCHIN D
HICKS R
PETERS L
HUGHES P
BINNS D
MAISANO R
HARVEY E
VONROEMELING R
Citation: D. Rischin et al., PET EVALUATION OF HYPOXIA AND RESPONSE IN LOCALLY ADVANCED HEAD AND NECK-CANCER TREATED ON A PHASE-I TRIAL OF RADIOTHERAPY, TIRAPAZAMINE AND CISPLATIN, Annals of oncology, 9, 1998, pp. 485-485
Authors:
TREAT J
RODRIGUEZ G
MILLER V
LANGER C
BIGELOW R
DEVIN J
LOCKWOOD G
VONROEMELING R
VIALLET J
KRIS M
Citation: J. Treat et al., AN INTEGRATED PHASE I II ANALYSIS OF TIRAZONE(TM) (TIRAPAZAMINE) PLUSCISPLATIN - SAFETY AND EFFICACY IN ADVANCED NONSMALL CELL LUNG-CANCER(NSCLC) PATIENTS/, Annals of oncology, 9, 1998, pp. 665-665
Authors:
AGHAJANIAN C
LEVENBECK C
CHEN Y
PEZZULLI S
BROWN C
CURTIN J
VONROEMELING R
SPRIGGS D
Citation: C. Aghajanian et al., A MULTICENTER PHASE-II STUDY OF TIRAPAZAMINE PLUS CISPLATIN IN PATIENTS WITH METASTATIC OR RECURRENT CERVICAL-CANCER, Annals of oncology, 9, 1998, pp. 666-666
Authors:
TREAT J
JOHNSON E
LANGER C
BELANI C
HAYNES B
GREENBERG R
RODRIQUEZ R
DROBINS P
MILLER W
MEEHAN L
MCKEON A
DEVIN J
VONROEMELING R
VIALLET J
Citation: J. Treat et al., TIRAPAZAMINE WITH CISPLATIN IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER - A PHASE-II STUDY, Journal of clinical oncology, 16(11), 1998, pp. 3524-3527
Authors:
LEE DJ
TROTTI A
SPENCER S
ROSTOCK R
FISHER C
VONROEMELING R
HARVEY E
GROVES EG
Citation: Dj. Lee et al., CONCURRENT TIRAPAZAMINE AND RADIOTHERAPY FOR ADVANCED HEAD AND NECK CARCINOMAS - A PHASE-II STUDY, International journal of radiation oncology, biology, physics, 42(4), 1998, pp. 811-815
Authors:
GATZEMEIER U
RODRIGUEZ G
TREAT J
MILLER V
VONROEMELING R
VIALLET J
REY A
Citation: U. Gatzemeier et al., TIRAPAZAMINE-CISPLATIN - THE SYNERGY, British Journal of Cancer, 77, 1998, pp. 15-17
Authors:
SENAN S
RAMPLING R
GRAHAN MA
WILSON P
ROBIN H
ECKARDT N
LAWSON N
MCDONALD A
VONROEMELING R
WORKMAN P
KAYE SB
Citation: S. Senan et al., PHASE-1 AND PHARMACOKINETIC STUDY OF TIRAPAZAMINE (SR-4233) ADMINISTERED EVERY 3 WEEKS (VOL 3, PG 31, 1997), Clinical cancer research, 3(9), 1997, pp. 1676-1676
Authors:
SENAN S
RAMPLING R
GRAHAM MA
WILSON P
ROBIN H
ECKARDT N
LAWSON N
MCDONALD A
VONROEMELING R
WORKMAN P
KAYE SB
Citation: S. Senan et al., PHASE-I AND PHARMACOKINETIC STUDY OF TIRAPAZAMINE (SR-4233) ADMINISTERED EVERY 3 WEEKS, Clinical cancer research, 3(1), 1997, pp. 31-38
Authors:
BEDIKIAN AY
LEGHA SS
ETON O
BUZAID AC
PAPADOPOULOS N
COATES S
SIMMONS T
NEEFE J
VONROEMELING R
Citation: Ay. Bedikian et al., PHASE-II TRIAL OF TIRAPAZAMINE COMBINED WITH CISPLATIN IN CHEMOTHERAPY OF ADVANCED MALIGNANT-MELANOMA, Annals of oncology, 8(4), 1997, pp. 363-367
Authors:
MILLER VA
NG KK
GRANT SC
KINDLER H
PIZZO B
HEELAN RT
VONROEMELING R
KRIS MG
Citation: Va. Miller et al., PHASE-II STUDY OF THE COMBINATION OF THE NOVEL BIOREDUCTIVE AGENT, TIRAPAZAMINE, WITH CISPLATIN IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER, Annals of oncology, 8(12), 1997, pp. 1269-1271
Authors:
JOHNSON CA
KILPATRICK D
VONROEMELING R
LANGER C
GRAHAM MA
GREENSLADE D
KENNEDY G
KEENAN E
ODWYER PJ
Citation: Ca. Johnson et al., PHASE-I TRIAL OF TIRAPAZAMINE IN COMBINATION WITH CISPLATIN IN A SINGLE-DOSE EVERY 3 WEEKS IN PATIENTS WITH SOLID TUMORS, Journal of clinical oncology, 15(2), 1997, pp. 773-780
Authors:
GRAHAM MA
SENAN S
ROBIN H
ECKHARDT N
LENDREM D
HINCKS J
GREENSLADE D
RAMPLING R
KAYE SB
VONROEMELING R
WORKMAN P
Citation: Ma. Graham et al., PHARMACOKINETICS OF THE HYPOXIC CELL CYTOTOXIC AGENT TIRAPAZAMINE ANDITS MAJOR BIOREDUCTIVE METABOLITES IN MICE AND HUMANS - RETROSPECTIVEANALYSIS OF A PHARMACOKINETICALLY GUIDED DOSE-ESCALATION STRATEGY IN A PHASE-I TRIAL, Cancer chemotherapy and pharmacology, 40(1), 1997, pp. 1-10
Authors:
AGHAJANIAN C
BROWN C
OFLAHERTY C
FLEISCHAUER A
CURTIN J
VONROEMELING R
SPRIGGS DR
Citation: C. Aghajanian et al., PHASE-I STUDY OF TIRAPAZAMINE AND CISPLATIN IN PATIENTS WITH RECURRENT CERVICAL-CANCER, Gynecologic oncology, 67(2), 1997, pp. 127-130
Risultati:
1-13
|